Cargando…
P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430081/ http://dx.doi.org/10.1097/01.HS9.0000849228.50385.a3 |
| _version_ | 1784779650476539904 |
|---|---|
| author | Tamariz-Amador, L.-E. Battaglia, A. M. Maia, C. Zherniakova, A. Guerrero, C. Zabaleta, A. Burgos, L. Botta, C. Fortuño, M.-A. Alignani, D. Blanco, L. Grande, C. Manubens, A. Arguiñano, J.-M. Gomez, C. Perez-Persona, E. Olazabal, I. Oiartzabal, I. Panizo, C. Prosper, F. San Miguel, J. F. Rodriguez-Otero, P. Martín-Sánchez, E. Paiva, B. ASOVASNA, A. V.-N. H.-H. |
| author_facet | Tamariz-Amador, L.-E. Battaglia, A. M. Maia, C. Zherniakova, A. Guerrero, C. Zabaleta, A. Burgos, L. Botta, C. Fortuño, M.-A. Alignani, D. Blanco, L. Grande, C. Manubens, A. Arguiñano, J.-M. Gomez, C. Perez-Persona, E. Olazabal, I. Oiartzabal, I. Panizo, C. Prosper, F. San Miguel, J. F. Rodriguez-Otero, P. Martín-Sánchez, E. Paiva, B. ASOVASNA, A. V.-N. H.-H. |
| author_sort | Tamariz-Amador, L.-E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430081 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94300812022-08-31 P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES Tamariz-Amador, L.-E. Battaglia, A. M. Maia, C. Zherniakova, A. Guerrero, C. Zabaleta, A. Burgos, L. Botta, C. Fortuño, M.-A. Alignani, D. Blanco, L. Grande, C. Manubens, A. Arguiñano, J.-M. Gomez, C. Perez-Persona, E. Olazabal, I. Oiartzabal, I. Panizo, C. Prosper, F. San Miguel, J. F. Rodriguez-Otero, P. Martín-Sánchez, E. Paiva, B. ASOVASNA, A. V.-N. H.-H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430081/ http://dx.doi.org/10.1097/01.HS9.0000849228.50385.a3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Tamariz-Amador, L.-E. Battaglia, A. M. Maia, C. Zherniakova, A. Guerrero, C. Zabaleta, A. Burgos, L. Botta, C. Fortuño, M.-A. Alignani, D. Blanco, L. Grande, C. Manubens, A. Arguiñano, J.-M. Gomez, C. Perez-Persona, E. Olazabal, I. Oiartzabal, I. Panizo, C. Prosper, F. San Miguel, J. F. Rodriguez-Otero, P. Martín-Sánchez, E. Paiva, B. ASOVASNA, A. V.-N. H.-H. P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title | P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_full | P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_fullStr | P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_full_unstemmed | P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_short | P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES |
| title_sort | p1593: immune biomarkers to predict sars-cov-2 vaccine effectiveness in patients with hematological malignancies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430081/ http://dx.doi.org/10.1097/01.HS9.0000849228.50385.a3 |
| work_keys_str_mv | AT tamarizamadorle p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT battagliaam p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT maiac p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT zherniakovaa p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT guerreroc p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT zabaletaa p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT burgosl p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT bottac p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT fortunoma p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT alignanid p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT blancol p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT grandec p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT manubensa p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT arguinanojm p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT gomezc p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT perezpersonae p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT olazabali p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT oiartzabali p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT panizoc p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT prosperf p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT sanmigueljf p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT rodriguezoterop p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT martinsancheze p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT paivab p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies AT asovasnaavnhh p1593immunebiomarkerstopredictsarscov2vaccineeffectivenessinpatientswithhematologicalmalignancies |